A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver.
By H. Klasen. Burns, 2000
833 citations recorded by the source corpus.
Subfields: Epidemiology, Oncology, Rehabilitation
View Paper: https://www.semanticscholar.org/paper/27d1935cc32a307aa4998295e7a9854aaf371a19
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Oncology
In Rehabilitation
Citations in the corpus
- Effect of silver on burn wound infection control and healing: review of the literature. (2007, background): “More substantive information on the bactericidal action of silver relates to its accumulation in the bacterial cells and its opportunity to interact with the cytosolic proteins, mitochondrial enzymes and nuclear DNA or RNA synthesis [45].”
- Twenty-Eight-Day Oral Toxicity, Genotoxicity, and Gender-Related Tissue Distribution of Silver Nanoparticles in Sprague-Dawley Rats (2008, background): “, 2006), along with the use of silver nanoparticles for the treatment of burns (Klasen 2000; Percival et al., 2005).”
- Green synthesis of silver nanoparticles using olive leaf extract and its antibacterial activity (2014, background): “The action of Ag-Nps on the bacteria was also due to the interaction with thiol group compounds found in the respiratory enzymes of bacterial cells thus inhibiting the respiration process in bacteria (Klasen, 2000, Li et al., 2010, 2011).”
- Assessment of Size-Dependent Antimicrobial and Cytotoxic Properties of Silver Nanoparticles (2014, background): “In 1960s, silver sulfadiazine was first used, as an antimicrobial compound, to cure burn patients [1– 3] and has also been used for a long time to deal with various diseases like cauterization, pleurodesis, and skin wounds [1, 4, 5].”
- Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds (2006, background): “[35] was licensed to Marion Laboratories (in 1969), with the US patent issued in 1973.”
- Bacterial resistance to silver in wound care. (2005, background): “Clinical evidence of silver-resistant bacteria has been principally in hospitals, specifically in burns wards, where silver salts (in the form of silver nitrate) are used as antiseptic agents.(13,27) Many clinicians and researchers have questioned whether the widespread usage of silver could lead to”
- Antifungal activity and mode of action of silver nano-particles on Candida albicans (2009, neutral): “Since ancient times it has been known that silver and its compounds are effective antimicrobial agents (Silver 2003; Klasen 2000).”